Liver Reference Set-Rapid-Application: Nilsson Glycobond (2018)
- Abbreviated Name
- Liver Rapid Ref Set App: Nilsson (2018)
- Lead Investigator
- Nilsson, Anki — Glycobond
- Coordinating Investigator
- Feng, Ziding — Fred Hutchinson Cancer Center
- Involved Investigators
Abstact
No abstract availalbe.
Aims
No aims available.
Analytic Method
No analytic method available.
Outcome
The HepaCheC biomarker demonstrated some discrimination between early-stage HCC cases (N=50) and cirrhotic controls (N=50) in the EDRN Liver Rapid Reference Set. The observed AUC was 0.59 (95% CI 0.47; 0.71) and the observed sensitivity at 90% specificity was 0.28 (95% CI 0.06; 0.4). The combination of HepaCheC and log-transformed AFP, which demonstrated: AUC = 0.80 (95% CI 0.71; 0.88) and sensitivity at 90% specificity = 0.58 (95% CI 0.36; 0.76), did not improve on AFP alone, which demonstrated: AUC = 0.80 (95% CI 0.71; 0.88) and sensitivity at 90% specificity = 0.58 (95% CI 0.4; 0.76). Subsequent analysis on subsets with Alcoholic Liver Disease (15 cases; 15 controls) and Hepatitis C Virus (27 cases; 32 controls) gave qualitatively similar results.
Publications
- No publications available at this time for this protocol.
Biomarkers
Data Collections
- No data collections available at this time for this protocol.
Team Project
- Start Date
- May 25 2018
- Estimated Finish Date
- Sep 25 2018
- Finish Date
- Jan 15 2019
- Protocol ID
- 446
- Protocol Type
- Reference Set
- Field of Research
- UNKNOWN
- Collaborative Group
- G.I. and Other Associated Cancers Research Group
- Cancer Types
-
- Liver cell carcinoma
- Phased Status
- 1